• 1. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles

2-3,5-Bis(difluoromethyl)-1H-pyrazol-1-ylethan-1-ol: A Comprehensive Overview

The compound with CAS No. 1006469-58-4, commonly referred to as 2-3,5-bis(difluoromethyl)-1H-pyrazol-1-ylethan-1-ol, has garnered significant attention in the fields of organic chemistry and materials science. This molecule is a derivative of pyrazole, a five-membered aromatic heterocycle with two nitrogen atoms. The presence of difluoromethyl groups at the 3 and 5 positions of the pyrazole ring introduces unique electronic and steric properties, making it a versatile building block for various applications.

Recent studies have highlighted the potential of 2-3,5-bis(difluoromethyl)-1H-pyrazol-1-ylethan-1-ol in drug discovery. Its structure allows for strong hydrogen bonding interactions, which are crucial in molecular recognition and bioavailability. Researchers have explored its role as a lead compound in the development of novel therapeutic agents targeting various diseases, including cancer and neurodegenerative disorders. The incorporation of difluoromethyl groups enhances the molecule's stability and bioactivity, making it a promising candidate for further investigation.

In addition to its pharmacological applications, CAS No. 1006469-58-4 has shown potential in materials science. Its ability to form stable coordination complexes with metal ions has led to its use in the synthesis of advanced materials such as metal-organic frameworks (MOFs) and coordination polymers. These materials exhibit exceptional porosity and surface area, making them ideal for gas storage and catalytic applications.

The synthesis of 2-3,5-bis(difluoromethyl)-1H-pyrazol-1-ylethan-1-ol involves a multi-step process that combines traditional organic synthesis techniques with modern catalytic methods. Key steps include the formation of the pyrazole ring through cyclization reactions and subsequent functionalization with difluoromethyl groups. Recent advancements in catalytic asymmetric synthesis have enabled the production of enantiomerically pure derivatives, further expanding its utility in chiral chemistry.

From an environmental perspective, the stability and biodegradability of CAS No. 1006469-58-4 have been thoroughly investigated. Studies indicate that it exhibits low toxicity to aquatic organisms under standard test conditions, suggesting its potential for use in eco-friendly chemical processes. However, further research is required to fully understand its long-term environmental impact.

In conclusion, 2-3,5-bis(difluoromethyl)-1H-pyrazol-1-ylethan

• 345637-71-0(2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetic acid)
• 956394-38-0(3-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-ylpropan-1-amine)
• 128694-64-4(1-ethyl-5-methyl-3-(trifluoromethyl)pyrazole)
• 512809-86-8(2-[5-(difluoromethyl)-3-methyl-1H-pyrazol-1-yl]acetic acid)
• 20000-80-0(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethan-1-ol)
• 957487-29-5(2-[3-(difluoromethyl)-5-methyl-1H-pyrazol-1-yl]acetic acid)
• 1006480-14-3(2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethan-1-ol)
• 1003320-00-0(2-3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-ylacetic acid)
• 1006344-06-4(2-(3-(trifluoromethyl)-1H-pyrazol-1-yl)ethan-1-ol)
• 925154-89-8(2-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-ylethanamine)